AI-generated summary
The authors compared photodynamic therapy using a 660 nm diode laser with 0.1% triamcinolone acetonide in 28 randomized patients with symptomatic oral lichen planus over one month. Both treatments significantly reduced pain and lesion size, with photodynamic therapy showing greater pain reduction, while biomarker changes were largely not significant.
- Participants
- 28
- Who or what was studied
- Patients with symptomatic oral lichen planus
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The abstract reports lesion size differences between groups were not statistically significant and biomarker changes were largely non-significant, with a trend rather than a confirmed advantage.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on ovid.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Power
- 100 mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photodynamic therapy, Biomarker, Visual analogue scale, Photobiomodulation, Randomized controlled trial, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.